WO2004011498A3 - Derives de peptide natriuretique de longue duree - Google Patents
Derives de peptide natriuretique de longue duree Download PDFInfo
- Publication number
- WO2004011498A3 WO2004011498A3 PCT/CA2003/001097 CA0301097W WO2004011498A3 WO 2004011498 A3 WO2004011498 A3 WO 2004011498A3 CA 0301097 W CA0301097 W CA 0301097W WO 2004011498 A3 WO2004011498 A3 WO 2004011498A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- long lasting
- natriuretic peptide
- peptide derivatives
- peptide
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Endocrinology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Zoology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Rheumatology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002488348A CA2488348A1 (fr) | 2002-07-31 | 2003-07-29 | Derives de peptide natriuretique de longue duree |
EP03771007A EP1530588A2 (fr) | 2002-07-31 | 2003-07-29 | Derives de peptide natriuretique de longue duree |
AU2003246500A AU2003246500A1 (en) | 2002-07-31 | 2003-07-29 | Long lasting natriuretic peptide derivatives |
JP2004523679A JP2006514607A (ja) | 2002-07-31 | 2003-07-29 | 長時間持続性ナトリウム排泄増加性ペプチド誘導体 |
US10/471,348 US20040266673A1 (en) | 2002-07-31 | 2003-07-29 | Long lasting natriuretic peptide derivatives |
US11/040,810 US20050176641A1 (en) | 2000-05-17 | 2005-01-21 | Long lasting natriuretic peptide derivatives |
US11/067,556 US7601691B2 (en) | 1999-05-17 | 2005-02-25 | Anti-obesity agents |
US11/923,222 US7906482B2 (en) | 1999-05-17 | 2007-10-24 | Anti-obesity agents |
US11/926,843 US20080199532A1 (en) | 1999-05-17 | 2007-10-29 | Long Lasting Natriuretic Peptide Derivatives |
US12/253,856 US20090275506A1 (en) | 2000-05-17 | 2008-10-17 | Long lasting natriuretic peptide derivatives |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40019902P | 2002-07-31 | 2002-07-31 | |
US40041302P | 2002-07-31 | 2002-07-31 | |
US60/400,413 | 2002-07-31 | ||
US60/400,199 | 2002-07-31 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/471,348 A-371-Of-International US20040266673A1 (en) | 1999-05-17 | 2003-07-29 | Long lasting natriuretic peptide derivatives |
US11/040,810 Continuation US20050176641A1 (en) | 1999-05-17 | 2005-01-21 | Long lasting natriuretic peptide derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004011498A2 WO2004011498A2 (fr) | 2004-02-05 |
WO2004011498A3 true WO2004011498A3 (fr) | 2004-06-24 |
Family
ID=31191354
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CA2003/001097 WO2004011498A2 (fr) | 1999-05-17 | 2003-07-29 | Derives de peptide natriuretique de longue duree |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1530588A2 (fr) |
JP (2) | JP2006514607A (fr) |
AU (1) | AU2003246500A1 (fr) |
CA (1) | CA2488348A1 (fr) |
WO (1) | WO2004011498A2 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7662773B2 (en) | 2002-11-26 | 2010-02-16 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
US9173950B2 (en) | 2012-05-17 | 2015-11-03 | Extend Biosciences, Inc. | Vitamin D-ghrelin conjugates |
US9585934B2 (en) | 2014-10-22 | 2017-03-07 | Extend Biosciences, Inc. | Therapeutic vitamin D conjugates |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7601691B2 (en) | 1999-05-17 | 2009-10-13 | Conjuchem Biotechnologies Inc. | Anti-obesity agents |
DE60226702D1 (de) | 2001-02-16 | 2008-07-03 | Conjuchem Biotechnologies Inc | Lang wirkendes glucagon-ähnliches peptid-2 für die behandlung von gastrointestinalen krankheiten und störungen |
US20050272650A1 (en) | 2004-02-17 | 2005-12-08 | Mohapatra Shyam S | Materials and methods for treatment of inflammatory and cell proliferation disorders |
AU2003268531A1 (en) | 2002-09-06 | 2004-03-29 | University Of South Florida | Materials and methods for treatment of allergic diseases |
US7648962B2 (en) * | 2002-11-26 | 2010-01-19 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
ES2887039T3 (es) | 2004-04-21 | 2021-12-21 | Alexion Pharma Inc | Conjugados para administración ósea y procedimiento de uso de estos para dirigir proteínas al hueso |
ATE496060T1 (de) | 2004-07-15 | 2011-02-15 | Univ Queensland | Proteinartige verbindungen und anwendungen davon |
MX2007010930A (es) * | 2005-03-07 | 2008-03-14 | Mondobiotech Licensing Out Ag | Formulacion de aviptadil. |
WO2006108686A2 (fr) * | 2005-04-14 | 2006-10-19 | Aic | Agonistes bnp |
US20080227713A1 (en) * | 2005-10-03 | 2008-09-18 | Protter Andrew A | Oxidized Human Bnp |
CA2656990A1 (fr) | 2006-04-28 | 2007-11-08 | University Of South Florida | Matieres et procedes destines a reduire une inflammation par inhibition du recepteur du peptide natriuretique auriculaire |
JP5010913B2 (ja) * | 2006-12-31 | 2012-08-29 | 寿子 小出 | 心房利尿ホルモンファミリー分子を活性物質として含有する組織再生製剤また該製剤をもちいる組織再生方法、および心房利尿ホルモンファミリー分子を活性物質として含有する発毛、増毛、育毛剤および皮膚組織修復改善剤また該製剤を用いる発毛、増毛、育毛促進方法および皮膚組織修復改善方法 |
KR20080098216A (ko) * | 2007-05-04 | 2008-11-07 | 한미약품 주식회사 | 캐리어 물질을 이용한 나트륨 배설 펩타이드 약물 결합체 |
JP2010530222A (ja) * | 2007-06-06 | 2010-09-09 | べーリンガー インゲルハイム インターナショナル ゲーエムベーハー | ナトリウム利尿融合タンパク質 |
EP2173773A4 (fr) * | 2007-07-06 | 2010-07-07 | Theratechnologies Inc | Protéines de fusion bifonctionnelles de l'hormone de stimulation des alpha-mélanocytes (alpha-msh) et de la protéine natriurétique auriculaire (pna), et leurs utilisations dans l'hypertension et la lésion rénale aiguë |
WO2012013597A1 (fr) | 2010-07-28 | 2012-02-02 | Justus-Liebig-Universität Giessen | Substances et utilisation desdites substances pour influer sur les récepteurs peptidiques natriurétiques |
DE102010032482A1 (de) | 2010-07-28 | 2012-02-02 | Justus-Liebig-Universität Giessen | Stoffe zur Beeinflussung der natriuretischen Peptid-Rezeptoren A und B und deren Verwendung |
CA2823066A1 (fr) | 2010-12-27 | 2012-07-05 | Alexion Pharma International Sarl | Compositions contenant des peptides natriuretiques et leurs methodes d'utilisation |
CN103402534B (zh) * | 2011-02-23 | 2016-10-12 | 麦德林制药私人有限公司 | 用于治疗充血性心力衰竭的治疗方法 |
US10184942B2 (en) | 2011-03-17 | 2019-01-22 | University Of South Florida | Natriuretic peptide receptor as a biomarker for diagnosis and prognosis of cancer |
CN102286092B (zh) | 2011-09-14 | 2014-01-01 | 深圳翰宇药业股份有限公司 | 利拉鲁肽的固相合成方法 |
US10052366B2 (en) | 2012-05-21 | 2018-08-21 | Alexion Pharmaceuticsl, Inc. | Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
US10822596B2 (en) | 2014-07-11 | 2020-11-03 | Alexion Pharmaceuticals, Inc. | Compositions and methods for treating craniosynostosis |
US9789197B2 (en) | 2014-10-22 | 2017-10-17 | Extend Biosciences, Inc. | RNAi vitamin D conjugates |
WO2016065052A1 (fr) | 2014-10-22 | 2016-04-28 | Extend Biosciences, Inc. | Conjugués insuline vitamine d |
WO2016090251A1 (fr) | 2014-12-05 | 2016-06-09 | Alexion Pharmaceuticals, Inc. | Traitement de crise avec une phosphatase alcaline recombinée |
EP3250227A2 (fr) | 2015-01-28 | 2017-12-06 | Alexion Pharmaceuticals, Inc. | Méthodes de traitement d'un sujet atteint d'une déficience en phosphatase alcaline |
KR20180010267A (ko) * | 2015-05-29 | 2018-01-30 | 가부시키가이샤 이기스 | 환상 펩티드 및 그 환상 펩티드를 포함한 의약, 외용제 및 화장료 |
MX2018002121A (es) | 2015-08-17 | 2018-06-18 | Alexion Pharma Inc | Elaboracion de fosfatasas alcalinas. |
US11229686B2 (en) | 2015-09-28 | 2022-01-25 | Alexion Pharmaceuticals, Inc. | Reduced frequency dosage regimens for tissue non-specific alkaline phosphatase (TNSALP)-enzyme replacement therapy of hypophosphatasia |
JP2018533571A (ja) | 2015-10-30 | 2018-11-15 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | 患者の頭蓋縫合早期癒合症を治療するための方法 |
EP3426286A4 (fr) | 2016-03-08 | 2019-12-04 | Alexion Pharmaceuticals, Inc. | Méthodes de traitement de l'hypophosphatasie chez l'enfant |
JP2019513711A (ja) | 2016-04-01 | 2019-05-30 | アレクシオン ファーマシューティカルズ, インコーポレイテッド | アルカリホスファターゼによって筋力低下を治療すること |
EP3436020A4 (fr) | 2016-04-01 | 2019-12-25 | Alexion Pharmaceuticals, Inc. | Méthodes de traitement de l'hypophosphatasie chez les adolescents et les adultes |
US10988744B2 (en) | 2016-06-06 | 2021-04-27 | Alexion Pharmaceuticals, Inc. | Method of producing alkaline phosphatase |
US11116821B2 (en) | 2016-08-18 | 2021-09-14 | Alexion Pharmaceuticals, Inc. | Methods for treating tracheobronchomalacia |
EP3600383A4 (fr) | 2017-03-31 | 2020-10-28 | Alexion Pharmaceuticals, Inc. | Méthodes de traitement de l'hypophosphatasie (hpp) chez l'adulte et l'adolescent |
WO2019190752A1 (fr) | 2018-03-30 | 2019-10-03 | Alexion Pharmaceuticals, Inc. | Production de glycoprotéines |
WO2024086680A2 (fr) | 2022-10-21 | 2024-04-25 | Eli Lilly And Company | Peptides natriurétiques à action prolongée et leurs utilisations |
CN116284329B (zh) * | 2023-04-28 | 2023-12-08 | 成都奥达生物科技有限公司 | 一种长效利钠肽化合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000069900A2 (fr) * | 1999-05-17 | 2000-11-23 | Conjuchem, Inc. | Protection de peptides therapeutiques endogenes contre l'activite peptidase par conjugaison de composants sanguins |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3042782B2 (ja) * | 1985-11-05 | 2000-05-22 | サイオス インコーポレイテッド | 心房性ナトリウム尿排泄亢進ペプチド類似化合物 |
IE862891L (en) * | 1985-11-05 | 1987-05-05 | Behringwerke Ag | Analogs of atrial natriuretic peptides |
WO1990014362A1 (fr) * | 1989-05-24 | 1990-11-29 | Abbott Laboratories | Derives de peptides atriaux |
CA2373252C (fr) * | 1999-05-17 | 2007-08-07 | Conjuchem Inc. | Peptides antiangiogeniques durables |
JP2003508501A (ja) * | 1999-09-07 | 2003-03-04 | コンジュケム,インコーポレーテッド | 生物学的結合のための肺送達 |
-
2003
- 2003-07-29 CA CA002488348A patent/CA2488348A1/fr not_active Abandoned
- 2003-07-29 EP EP03771007A patent/EP1530588A2/fr not_active Ceased
- 2003-07-29 AU AU2003246500A patent/AU2003246500A1/en not_active Abandoned
- 2003-07-29 WO PCT/CA2003/001097 patent/WO2004011498A2/fr active Application Filing
- 2003-07-29 JP JP2004523679A patent/JP2006514607A/ja active Pending
-
2009
- 2009-12-01 JP JP2009273992A patent/JP2010047614A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000069900A2 (fr) * | 1999-05-17 | 2000-11-23 | Conjuchem, Inc. | Protection de peptides therapeutiques endogenes contre l'activite peptidase par conjugaison de composants sanguins |
Non-Patent Citations (1)
Title |
---|
LEGER ROGER ET AL: "Synthesis and in vitro analysis of atrial natriuretic peptide-albumin conjugates.", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, vol. 13, no. 20, 20 October 2003 (2003-10-20), pages 3571 - 3575, XP001156881, ISSN: 0960-894X * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7662773B2 (en) | 2002-11-26 | 2010-02-16 | Biocon Limited | Natriuretic compounds, conjugates, and uses thereof |
US9173950B2 (en) | 2012-05-17 | 2015-11-03 | Extend Biosciences, Inc. | Vitamin D-ghrelin conjugates |
US9289507B2 (en) | 2012-05-17 | 2016-03-22 | Extend Biosciences, Inc. | Carriers for improved drug delivery |
US9585934B2 (en) | 2014-10-22 | 2017-03-07 | Extend Biosciences, Inc. | Therapeutic vitamin D conjugates |
Also Published As
Publication number | Publication date |
---|---|
CA2488348A1 (fr) | 2004-02-05 |
AU2003246500A1 (en) | 2004-02-16 |
JP2010047614A (ja) | 2010-03-04 |
EP1530588A2 (fr) | 2005-05-18 |
WO2004011498A2 (fr) | 2004-02-05 |
JP2006514607A (ja) | 2006-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004011498A3 (fr) | Derives de peptide natriuretique de longue duree | |
WO2004066805A3 (fr) | Dispositif in vivo destine a ameliorer la fonction ventriculaire diastolique | |
WO2000069900A3 (fr) | Protection de peptides therapeutiques endogenes contre l'activite peptidase par conjugaison de composants sanguins | |
EP1408038A3 (fr) | Dérivés d'imidazole et leur utilisation en tant qu'inhibiteurs périphère-sélectives de bèta-hydroxylase | |
AU2001257620A1 (en) | Supplemental heart pump methods and systems for supplementing blood through the heart | |
WO2001037850A3 (fr) | Utilisation d'hydrolysat de proteine de lait dans le traitement des diabetes | |
AU2003212961A1 (en) | Split tip dialysis catheter | |
WO2003079979A3 (fr) | Procede de traitement d'insuffisance cardiaque globale | |
AU2001251514A1 (en) | Method for detecting cheyne-stokes respiration in patients with congestive heart failure | |
EP1421927A4 (fr) | Agent dentaire de decapage a mordancage spontane | |
AU2003240581A1 (en) | Ventricular connector | |
AU2002234207A1 (en) | Low profile pivoting joint infusion assembly | |
EP1534358B8 (fr) | Ouie d'aspiration au profil bas pour pompe a sang implantable | |
WO2003096977A3 (fr) | Methodes de traitement de l'hepatite | |
WO2004075852A3 (fr) | Compositions, combinaisons et methodes de traitement d'etats cardio-vasculaires et d'autres etats associes | |
AU2003260491A1 (en) | Vascular prosthesis, especially for replacing the ascending aorta | |
WO2003092541A3 (fr) | Supports orthopediques durcissables | |
WO2001091826A3 (fr) | Conception d'aiguille et procede de fabrication ameliores destines a des applications medicales | |
AU2003268218A1 (en) | Flexible composite guidewire for intravascular catheter | |
AU2003257187A1 (en) | Dialysis catheters with optimized user-friendly connections | |
AU2003278362A1 (en) | Method of forward error correction | |
AU2003214210A1 (en) | Treatment of congestive heart failure with natriuretic peptide and a diuretic | |
AU2003211107A1 (en) | Method for curing cyanoacrylate adhesives | |
WO2005042063A8 (fr) | Piece extra-aortique | |
AU5107296A (en) | Aminotetralin derivative for the therapy of cardiovascular diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 10471348 Country of ref document: US |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2488348 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003246500 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003771007 Country of ref document: EP Ref document number: 2004523679 Country of ref document: JP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003771007 Country of ref document: EP |